Rare lephants
Screener

Vistagen Therapeutics, Inc.

VTGN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jun 15, 2026 8-K
8-K Jun 9, 2026 8-K
4 May 19, 2026
3 May 19, 2026
8-K May 19, 2026 8-K
SCHEDULE 13G/A May 15, 2026
8-K May 12, 2026 8-K
8-K May 8, 2026 8-K
8-K Apr 28, 2026 8-K
8-K Apr 13, 2026 8-K
4 Apr 9, 2026 PRIMARY DOCUMENT
4 Apr 9, 2026 PRIMARY DOCUMENT
4 Apr 9, 2026 PRIMARY DOCUMENT
4 Apr 9, 2026 PRIMARY DOCUMENT
4 Apr 9, 2026 PRIMARY DOCUMENT
8-K Apr 2, 2026 8-K
8-K Mar 18, 2026 8-K
8-K Mar 16, 2026 8-K
8-K Mar 11, 2026 8-K
8-K Feb 20, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
← Newer Page 2 of 37 · 909 filings Older →